Summary: This study was designed to clarify the postoperative major complications of total pelvic exenteration for locally advanced colorectal cancer. Twenty-six patients (primary disease: 17, recurrent disease: 9) were retrospectively studied. Major complications developed in 30.8% (8 of 26); in 23.5% (4 of 17) for a primary disease and in 44.4% (4 of 9) for a recurrent disease. Only 2 patients (7.7%) died within 30 days after the operation; one patient died of hepatic failure and another of pelvic sepsis. Postoperative ileus developed at a high rate of 11.5% (3 of 26). Ileo-ileal anastomotic leakage developed at a rate of 7.7% (2 of 26) and it commonly occurred following irradiation. The remaining one patient had gastrointestinal bleeding. These 6 patients surviving the operation were successfully managed conservatively. Conclusion was as follows: Total pelvic exenteration should be performed carefully and aggressively regardless of the development of postoperative complications.
Introduction
Although total pelvic exenteration for an advanced colorectal cancer localized to the pelvic region remains a formidable procedure, such aggressive surgical procedure is required for a curative treatment of a primary or recurrent disease. The complete removal of involved adjacent organs (such as the vagina, uterus, bladder, and prostatic gland) has been shown to be effective in controlling the local disease and improving symptoms. However, severe complications may develop compared with a standard resection for colorectal carcinoma (Bonfanti et al. 1982; McGlone et al. 1982; Sugarbaker and Corlew, 1982; Pittman et al. 1984; Orkin et al. 1989; Hafner et al. 1992 ). This study was designed to clarify the postoperative major complications of total pelvic exenteration for locally advanced colorectal cancer. SHIROUZU ET AL.
Subjects and Methods
Total pelvic exenteration was performed on 26 patients with a primary or recurrent colorectal cancer during the period from January 1975 to March 1992 at the Kurume University. These patients were retrospectively studied with respect to major postoperative complications. Seventeen patients (14males and 3 females) had a primary disease, with a mean age of 55.1years (range, 42 to 88 years), and 9 patients (3 males and 6 females) had a recurrent disease, with a mean age of 55.9years (range, 33 to 67 years).
Preoperative radiotherapy was performed in 3 patients (two with a primary disease and one with a recurrent disease).
A major complication is defined as a significant complication requiring a further surgical procedure or long-term hospitalization.
Operative mortality is defined as death within 30days after the total pelvic exenteration.
The postoperative pathological stage was defined according to the new, internationally accepted, fourth edition of the UICC TNM classification (Hermanek and Sobin, 1987; Beahrs et al. 1988 As shown in Table 1 , the overall major complication rate was 30.8% (8 of 26) and the overall mortality rate was 7.7% (2 of 26).
Of the 17 patients who had a primary disease, 4 had a major complication (23.5%). Two of these 4 patients had postoperative ileus and recovered with conservative therapy. One patient had an ileo-perineal fistula due to ileo-ileal anastomotic leakage. This patient had previously received radiotherapy for a uterine cervical cancer 19years ago. Several re-operations were performed for the leakage. She recovered and has survived 3years to date. The remaining one patient, who received preoperative radiotherapy for a primary disease, died of pelvic sepsis 20days after the operation. The operative mortality rate was therefore 5.9% (1 of 17).
Of the 9 patients who had a recurrent disease, 4 had a major complication (44.4%). Postoperative ileus and upper gastrointestinal bleeding developed in one patient each, and both were successfully treated conservatively. One patient had an ileo-perineal fistula due to ileoileal anastomotic leakage, and had previously received radiotherapy for a uterine cervical cancer 17years ago. This patient was successfully managed conservatively. The remaining patient fell into shock due to intraoperative massive bleeding (30,000ml), and died of hepatic failure 26 days after the operation. The operative mortality rate was therefore 11.1%
(1 of 9).
Discussion
Pelvic exenteration for locally advanced pelvic cancer was first reported by Bruns chwig (1948). Appleby (1950) applied the same surgical principles in a series of eight male patients who had undergone proctocystectomy. This procedure can provide a reasonable treatment option for either primary or recurrent disease. However, this procedure has always been associated with considerable postoperative complications. Although the criteria for reporting postoperative complications may vary among authors, it develops at a high rate of 26% to 100% (Eckhauser et al. 1979; Boey et al. 1982; Jakowatz et al. 1985; Lopez et al. 1987; Hafner et al. 1992) . Excluding minor complications, the following causes of complications have been reported (Ledesma et al. 1981; Boey et al. 1982; Jakowatz et al. 1985; Lindsey et al. 1985; Lopez et al. 1987 Lopez et al. (1987) also reported that both short-and long-term complications were especially apparent in patients who had undergone the operation for carcinoma of the cervix after primary treatment by irradiation.
Pelvic sepsis developed in one patient who had previously received preoperative radiation therapy for a primary tumor. In this patient, Gramnegative bacteria may have easily infected the pelvic cavity because of severe diabetes mellitus and radiation damage. Although it is difficult to define the term "unresectable" in reference to extensive pelvic cancers, preoperative irradiation therapy may convert an unresectable tumor to a resectable one (Pillepich et al. 1978) . Careful attention should be paid to the high complication rate caused by prior irradiation as described by some authors (Jakowatz et al. 1985; Hafner et al. 1992) .
The overall mortality rate of 7.7% (2 of 26) in our series is similar to that in recent reports (Boey et al. 1982; Lopez et al. 1987; Hafner et al.1992 ). This rate can be expected to be further reduced in the future by improved preoperative planning and postoperative management. Boey et al.(1982) also attributed recent improvement to better patient selection, greater attention to technical detail, and improved nutritional and respiratory care during the perioperative period. In our series, although major complications developed at a high rate, most patients were successfully managed conservatively. Total pelvic exenteration can provide a symptomatic relief from cancer in the majority of patients and also improve the quality of their lives for the time remaining to them. We conclude that total pelvic exenteration for locally advanced colorectal cancer should be performed carefully and aggressively regardless of the development of complications.
